24.01.2021 Views

Extracorporeal Membrane Oxygenation Market

The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period. The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.

The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period. The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Extracorporeal Membrane Oxygenation Market is

Anticipated to Exceed CAGR of 4.3% at 2024

“The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at

USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast

period. The major factors boosting growth are the rising incidences of Chronic

Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary

diseases and respiratory failures.”

Industry Insights

The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is

expected to grow at CAGR of 4.3% over the forecast period. The major factors boosting growth are the rising incidences

of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory

failures.

According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest

cause of death across the U.S. In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S.

and 11.0 million diagnosed for COPD.

Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both,

females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD. ECMO

machines are gaining popularity in the hospital and healthcare systems due to the rising trend of its application during

cases of respiratory disorders.

The ECMO machines are used in cases of cardiac failure to facilitate auxiliary oxygen support system. These machines are

frequently used in patients suffering from respiratory conditions and also in neonates and pediatric patients. The

estimated growth of these machines can be attributed to the critical nature of the target population consisting of

neonates and pediatric patients.

Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/extracorporealmembrane-oxygenation-ecmo-market/request-sample

Modality Insights


The segmentation of the key modalities is done on the basis of the different setups that are provided by the ECMO circuit

such as arterio-venous, veno-arterial and veno-venous. They are used to provide hemodynamic support and to facilitate

gaseous exchange in patients with cardiac or respiratory failure.

Both gas exchange support and hemodynamic support is provided by the veno-arterial ECMO system. It majorly works by

passing the blood flow from the patients’ heart and lungs to the ECMO circuit. The veno-venous ECMO system on the

other hand facilitates sole gas exchange support in which the blood is made to return to the heart prior to pulmonary

circulation. According to the U.S. National Institute of Health (NIH), combination of veno-venous and veno-arterial is

used in specific cases such as cardiogenic shock.

Applications Insights

As per applications, the market is segmented into Extracorporeal Cardiopulmonary Resuscitation (ECPR), respiratory and

cardiac. The segments are further segmented on the basis of who is using the set up into adult application, neonate and

pediatric. The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based

ECMO.

The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory

conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health

disorders. As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic

bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.

Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/extracorporealmembrane-oxygenation-ecmo-market

Regional Insights

The major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA. North America has

grown considerably in this segment majorly attributed to the well developed primary, secondary and tertiary care

hospitals combined with the reimbursement network, increasing awareness about the ECMO system facilitating their

rapid adoption in the hospitals and favorable government funding.

Refinements in the technology presently in use was made by Terumo Cardiovascular Systems Corporation during the

production of CAPIOX FX Oxygenator. This system is expected tohelp in increasing the blood rate and offer complete

control over the entire process.

Competitive Market Share Insights

Some key players operating in the ECMO market include MAQUET Holding B. V. & Co. KG, Microport Scientific

Corporation, Medos Medizintechnik AG, Sorin Group, Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and

Nipro Medical Corporation. The major strategic initiatives adopted by the companies in this vertical are technological

advancements in the existing portfolio and new product development.

For example, Medtronic Plc designed Minimax Plus Oxygen System for patients from wide ranging age groups such as

from neonates to children, with features such as venous air director and low arterial port, which are integrated in the

system to increase the safety levels and performance.

Market Segment:


Modality Outlook (Revenue, USD Million, 2013 - 2024)

• Veno-Arterial

• Veno-Venous

• Arterio-Venous

Application Outlook (Revenue, USD Million, 2013 - 2024)

• Respiratory

• Neonates

• Pediatric

• Adult

• Cardiac

• Neonates

• Pediatric

• Adult

• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

• Neonates

• Pediatric

• Adult

Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• Asia Pacific

• Japan

• China

• Latin America

• Brazil

• Mexico

• MEA

• South Africa

• Saudi Arabia

Read Sample report of this Category: https://www.millioninsights.com/industry/medical-devices


Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.

Our representatives strive to understand diverse client requirements and cater to the same with

the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com

Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016

India

Phone: 91-20-65300184

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!